Related references
Note: Only part of the references are listed.Frequency of CCR5 genotypes in HIV-infected patients in Roraima, Brazil
Andre de Lima Guerra Corado et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2016)
Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors
Wenwen Chen et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice
Hannelouise Kissow et al.
REGULATORY PEPTIDES (2012)
Biased Signaling Pathways in β2-Adrenergic Receptor Characterized by 19F-NMR
Jeffrey J. Liu et al.
SCIENCE (2012)
Crystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and Carvedilol
Tony Warne et al.
STRUCTURE (2012)
Overview of the CCP4 suite and current developments
Martyn D. Winn et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Small molecule HIV entry inhibitors: Part I. Chemokine receptor antagonists: 2004-2010
Inder Pal Singh et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Allosteric and Orthosteric Sites in CC Chemokine Receptor (CCR5), a Chimeric Receptor Approach
Stefanie Thiele et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Agonist-Induced Internalization of CC Chemokine Receptor 5 as a Mechanism to Inhibit HIV Replication
Thierry Ferain et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Guillaume Lebon et al.
NATURE (2011)
The structural basis of agonist-induced activation in constitutively active rhodopsin
Jorg Standfuss et al.
NATURE (2011)
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Soren G. F. Rasmussen et al.
NATURE (2011)
Structure and function of an irreversible agonist-β2 adrenoceptor complex
Daniel M. Rosenbaum et al.
NATURE (2011)
Crystal structure of the β2 adrenergic receptor-Gs protein complex
Soren G. F. Rasmussen et al.
NATURE (2011)
IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data
Joanna L. Sharman et al.
NUCLEIC ACIDS RESEARCH (2011)
Structure of an Agonist-Bound Human A2A Adenosine Receptor
Fei Xu et al.
SCIENCE (2011)
Emerging concepts and approaches for chemokine-receptor drug discovery
Morgan O'Hayre et al.
EXPERT OPINION ON DRUG DISCOVERY (2010)
A Conserved Aromatic Lock for the Tryptophan Rotameric Switch in TM-VI of Seven-transmembrane Receptors
Birgitte Holst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Molecular Basis for Agonism in the BB3 Receptor: An Epitope Located on the Interface of Transmembrane-III, -VI, and -VII
F. Gbahou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5
John C. Tilton et al.
JOURNAL OF VIROLOGY (2010)
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Sudarshan Rajagopal et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
β-arrestin- but not G protein-mediated signaling by the decoy receptor CXCR7
Sudarshan Rajagopal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Beili Wu et al.
SCIENCE (2010)
β-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice
Robert W. Walters et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Four-Dimensional Docking: A Fast and Accurate Account of Discrete Receptor Flexibility in Ligand Docking
Giovanni Bottegoni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Targeting CXCR4 in HIV Cell-Entry Inhibition.
A. Steen et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Conformational Toggle Switches Implicated in Basal Constitutive and Agonist-Induced Activated States of 5-Hydroxytryptamine-4 Receptors
Lucie P. Pellissier et al.
MOLECULAR PHARMACOLOGY (2009)
Ligand binding and micro-switches in 7TM receptor structures
Rie Nygaard et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Flexible ligand docking to multiple receptor conformations: a practical alternative
Maxim Totrov et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2008)
3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354):: A partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice
Graeme Semple et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Modeling and molecular dynamics simulation of the human gonadotropin-releasing hormone receptor in a lipid bilayer
Eduardo Jardon-Valadez et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2008)
Structure of a β1-adrenergic G-protein-coupled receptor
Tony Warne et al.
NATURE (2008)
Highly potent, fully recombinant anti-HIV chemokines: Reengineering a low-cost microbicide
Hubert Gaertner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist
Veli-Pekka Jaakola et al.
SCIENCE (2008)
High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor
Vadim Cherezov et al.
SCIENCE (2007)
Crystal structure of the human β2 adrenergic G-protein-coupled receptor
Soren G. F. Rasmussen et al.
NATURE (2007)
A unique mechanism of β-blocker action:: Carvedilol stimulates β-arrestin signaling
James W. Wisler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Toward high-resolution prediction and design of transmembrane helical protein structures
P. Barth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nicotinic acid receptor agonists differentially activate downstream effectors
Jeremy G. Richman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism
Birgitte Holst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry
Mike Westby et al.
JOURNAL OF VIROLOGY (2007)
Functional selectivity and classical concepts of quantitative pharmacology
Jonathan D. Urban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Structural and molecular interactions of CCR5 inhibitors with CCR5
K Maeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-Chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro
K Maeda et al.
JOURNAL OF VIROLOGY (2004)
Identification of a novel site within G protein α subunits important for specificity of receptor-G protein interaction
A Heydorn et al.
MOLECULAR PHARMACOLOGY (2004)
Common structural basis for constitutive activity of the ghrelin receptor family
B Holst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The CXC chemokine receptor encoded by herpesvirus saimiri, ECRF3, shows ligand-regulated signaling through Gi, Gq, and G12/13 proteins but constitutive signaling only through Gi and G12/13 proteins
MM Rosenkilde et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry
F Tsamis et al.
JOURNAL OF VIROLOGY (2003)
Sequence analyses of G-protein-coupled receptors: Similarities to rhodopsin
T Mirzadegan et al.
BIOCHEMISTRY (2003)
Binding of 2-aryl-4-(piperidin-1-yl)butanamines and 1,3,4-trisubstituted pyrrolidines to human CCR5: A molecular modeling-guided mutagenesis study the binding pocket
LA Castonguay et al.
BIOCHEMISTRY (2003)
The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle
C Blanpain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
JM Strizki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Crystal structure of rhodopsin: A G protein-coupled receptor
K Palczewski et al.
SCIENCE (2000)
Discovery of novel, potent, and selective small-molecule CCR5 antagonists as anti-HIV-1 agents: Synthesis and biological evaluation of anilide derivatives with a quaternary ammonium moiety
M Shiraishi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
T Dragic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
